GlycoEra raised €114M in a Series B round in May 2025. The company is based in Schlieren, Switzerland. Investors in the round: 5AM Ventures, Agent Capital, Bristol Myers Squibb and 8 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
